Clinical trial Recruiting at 1 site Interventional Ages 18 to 39

Group program to help young adult cancer survivors improve their quality of life

Official title: Determining the Impact of a Curriculum for a Cancer Survivorship Group for Adolescents and Young Adults (AYA)

Run by Mayo Clinic · NCT05584449 · Data updated 2026-11-12

This study tests a 6-week online program designed to help young adult cancer survivors improve their quality of life by connecting with peers and learning coping skills.

More Malignant Solid Neoplasm trials

Quick facts

Study typeInterventional
Ages18 Years to 39 Years
SexAll
Enrollment60 (estimated)
SponsorMayo Clinic
Academic / other
Locations1 site (Scottsdale, Arizona)
StatusRecruiting
StartedJanuary 16, 2023
Main results expectedOctober 18, 2027
Study endsOctober 18, 2027
Registry record updatedJanuary 30, 2026
Trial IDNCT05584449 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are young adults aged 18-39 who have completed cancer treatment within the last 6 months to 2 years and are receiving care at Mayo Clinic Arizona.

Probably not a fit

Patients currently undergoing cancer treatment or those with severe concurrent illnesses may not benefit from this program.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates a 6-week group curriculum aimed at enhancing survivorship outcomes for adolescent and young adult (AYA) cancer survivors. The program, facilitated by licensed social workers, focuses on providing psychoeducational support and skill-building to help participants navigate the challenges of life after cancer treatment. Participants will engage in online discussions with peers, addressing survivorship issues and sharing coping strategies. The study aims to assess the effectiveness and feasibility of this tailored intervention for AYA cancer survivors.

Why it matters

Potential benefit: If successful, this program could significantly improve the quality of life for young adult cancer survivors by providing them with essential support and resources.

How similar studies have gone: Other studies have shown promise in using structured group interventions for cancer survivors, indicating potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18-39
* Is a patient of Mayo Clinic Arizona for oncologic care and/or follow-up
* History of cancer diagnosis
* Treated with curative intent
* Completed cancer treatment within 6 months to 2 years prior to group attendance
* Ability to read/write/speak English
* Ability to participate in a group setting
* Ability to commit to attending all six group meetings

Exclusion Criteria:

* Inability to read/write/speak English
* No internet or computer access
* Not receiving care at Mayo Clinic Arizona
* Currently receiving treatment for cancer
* Is unable to sit comfortably for 90 minutes
* Was not treated with curative intent
* Is on hospice care
* Co-morbid systemic illness or other severe concurrent disease which, in the judgment of the investigator, would make the patient inappropriate for entry into this study or interfere significantly with the proper assessments

Where it's running

  • Mayo Clinic in Arizona
    Scottsdale, Arizona, United States
    Recruiting

Study contacts

  • Principal investigator: Melody A Griffith, MSW, LISW — Mayo Clinic

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.